Mpox clinical trials at UCSD

1 research study open to eligible people

Showing trials for

  • Tecovirimat for Human Mpox Virus

    open to all eligible people

    A5418 is a randomized, placebo-controlled, double-blind study to establish the efficacy of tecovirimat for the treatment of people with laboratory-confirmed or presumptive HMPXV disease.

    San Diego, California and other locations

Last updated: